Shengquan Group: It plans to buy back shares at a price of 250 million yuan to 500 million yuan. Shengquan Group announced that it plans to buy back shares by centralized bidding, and the estimated repurchase amount is 250 million yuan to 500 million yuan. The sources of funds are self-owned funds and special loans for stock repurchase. The repurchase price does not exceed 32 yuan/share, and the repurchased shares will be used for employee stock ownership plan or equity incentive. The repurchase period is 12 months from the date when the board of directors deliberated and approved this repurchase plan. The controlling shareholder, actual controller and Dong Jiangao of the company have no plans to reduce their holdings in the next 3 months and 6 months.Dutch police arrested three suspects in the apartment bombing in The Hague. On the 10th local time, Dutch police arrested three suspects involved in the apartment bombing in The Hague. According to the police, the three suspects entered the police field of vision during a large-scale investigation into the cause of the explosion. Shortly after the explosion, three people drove away from the scene in a car. At present, the police have not released more details of the case. On the morning of the 7th of this month, an explosion occurred in a commercial and residential building in The Hague, the Netherlands, which partially collapsed and caught fire. Six people were killed in the incident and four people were seriously injured for medical treatment. (CCTV News)White House: The Ministry of Commerce has agreed to the preliminary terms of an additional investment of $275 million with Micron Technology (MU.O) to expand the factory in Manacas, Virginia.
Liu Kebin was appointed as the deputy mayor of Shenyang. According to the appointment and dismissal list of the Standing Committee of Shenyang Municipal People's Congress announced on December 10th, Liu Kebin was appointed as the deputy mayor of Shenyang Municipal People's Government. Liu Kebin, male, Han nationality, born in February 1967, holds an on-the-job university degree in party member, CPC. He used to be the director of the president's office of Shenyang University and the vice president of Shenyang University. In 2021, he became the director of Shenyang Sports Bureau, and in March 2023, he became the director of Shenyang Cultural Tourism and Radio and Television Bureau.Shengquan Group: It plans to buy back shares at a price of 250 million yuan to 500 million yuan. Shengquan Group announced that it plans to buy back shares by centralized bidding, and the estimated repurchase amount is 250 million yuan to 500 million yuan. The sources of funds are self-owned funds and special loans for stock repurchase. The repurchase price does not exceed 32 yuan/share, and the repurchased shares will be used for employee stock ownership plan or equity incentive. The repurchase period is 12 months from the date when the board of directors deliberated and approved this repurchase plan. The controlling shareholder, actual controller and Dong Jiangao of the company have no plans to reduce their holdings in the next 3 months and 6 months.US natural gas futures fell 3.00% in the day and are now reported at $3.086/million British heat.
The death toll from the collapse of a residential building in Cairo, Egypt, rose to eight. In the early morning of December 10, local time, an old five-story residential building collapsed in Abasia District, Cairo, Egypt. The local civil defense department has rushed to the scene to carry out search and rescue work. Up to now, the bodies of eight victims have been found and six others have been rescued. The procuratorate has been involved in the accident investigation. (CCTV News)Spokesman of the Ministry of Foreign Affairs of Qatar: All doors and communication channels are open for dialogue with Syrian parties on the future of Syria.AstraZeneca's potential blockbuster ADC was recognized by the FDA. AstraZeneca and Thirteen announced that the FDA granted its Trop2 targeted antibody-coupled drug (ADC) Datopotamab Deruxtecan (Dato-DXD) breakthrough therapy recognition (BTD) to treat adult patients with locally advanced or metastatic epidermal growth factor receptor mutation (EGFRm) who are undergoing treatment.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
Strategy guide 12-13
Strategy guide
12-13
Strategy guide